About UsProductsNewsClinical TrialCorporate RelationsResources

Recent Press Releases

Upcoming Events


Aug 27, 2010 AAT Granted US Patent for Novel Catheter Lock/Flush
June 24, 2009 AAT's PMA for Zuragen® Solution Accepted for Filing by FDA
Aug 22, 2008 AAT Completes AZEPTIC Trial for Zuragen™ Injection
Feb 11, 2008 Dr. Stephen Ash Receives Lifetime Achievement Award
Jan 25, 2008 AAT and AngioDynamics Release Centros™ Study Results
Jan 24, 2008 AAT Completes Patient Enrollment in Zuragen®'s AZEPTIC Trial
Jan 17, 2008 AAT Partners with AngioDynamics on New Dialysis Catheter
Jan 11, 2007 AAT Appoints VP of Scientific and Quality Affairs
Nov 15, 2006 Dr. Ash to Present Clinical Abstract for Zuragen™ at ASN
Oct 2, 2006 Patient Enrollment Initiated in Zuragen™ Pivotal Trial
Jul 5, 2006 AAT Receives $2M Grant from Indiana
Feb 16, 2006 AAT Partners with DaVita Clinical Research for FDA Trial
Jan 24, 2006 Bear Stearns Leads Series B Round for AAT
Sep 14, 2005 AAT Receives $2.7M NIH Grant for Clinical Trial
Aug 9, 2005 AAT Appoints VP of Sales and Marketing
May 13, 2005 AAT-023 Completely Eradicates Biofilm in Lab Studies
May 4, 2005 AAT-023 Shows Significant Antimicrobial Lab Results
March 22, 2005 FDA Notifies AAT of Approved IDE for AAT-023